CONTEXT: The effectiveness of many interventions aimed at reducing the risk of retinopathy has not been well established.
Retinopathy of prematurity (ROP) is a disorder of the developing retina in preterm infants and is a leading cause of childhood blindness. 1 ROP primarily affects neonates born at <32 weeks gestational age, with the risk and severity of ROP increasing with decreasing gestational age. Depending on the population studied, 20% to 50% of very low birth weight (VLBW, birth weight <1500 g) infants will develop ROP, with 4% to 19% having severe ROP (stages 3-5). 1, 2 Although incompletely understood, the pathogenesis of ROP involves multiple signaling factors and has been characterized by 2 phases. 3 The first phase begins after preterm birth and involves growth cessation of the retinal vasculature. Then at ∼32 weeks postmenstrual age, retinal neovascularization begins, marking the initiation of phase 2. Although preterm delivery is the primary risk factor for the development of ROP, multiple other modifiable clinical factors have been associated with an increased risk of ROP. These correlate well with the current understanding of ROP pathogenesis and include poor postnatal weight gain in the first 6 weeks of life, 4, 5 hyperoxia, [6] [7] [8] exposure to packed red blood cell (PRBC) transfusions, 9, 10 and late onset sepsis. [11] [12] [13] The objective of this meta-analysis was to study the effect and magnitude of the benefit of multiple interventions aimed at the prevention of ROP in preterm neonates <32 weeks gestational age. Four categories of interventions were selected based on the current understanding of ROP pathophysiology and included: (1) postnatal nutrition, (2) management of supplemental oxygen, (3) PRBC transfusions, and (4) infection reduction.
METHODS

Evidence Acquisition
This systematic review is reported according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. 14 
Data Sources and Search Strategy
A comprehensive search of several databases was conducted from each database's earliest inception to March 2014, any language, in infants. The databases included Ovid Medline In-Process & Other Non-Indexed Citations, Ovid Medline, Ovid Embase, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus. The search strategy was designed and conducted by an experienced librarian with input from the study's principal investigator. Controlled vocabulary supplemented with keywords was used to search for comparative studies of interventions for the prevention of ROP. The actual strategy is available in the Supplemental Information. To identify additional candidate studies, we reviewed reference lists from eligible studies.
Selection of Studies
Initial screening of the identified studies was performed by 4 independent reviewers working in duplicates based on the titles and abstracts, taking into consideration the inclusion criteria. After removing irrelevant and non-original studies, full-text screening was then performed to assess eligibility for final inclusion. Discrepancies were resolved through discussion and consensus.
We used a list of inclusion criteria set a priori for the initial and full article screening. We sought studies that included preterm infants <32 weeks gestational age who were cared for in a NICU. Interventions of interest comprised 4 main categories including postnatal nutritional interventions, management of supplemental oxygen, PRBC transfusions, and interventions aimed at reducing infections. Main outcomes of interest were incidence of any stage ROP, severe ROP (defined as stage [3] [4] [5] , and ROP requiring bevacizumab or surgical treatment. Because the interventions of interest could potentially impact mortality, we also collected data on in-hospital any-cause mortality.
We included comparative original studies (randomized or observational) and excluded single arm studies. Both randomized and observational studies were included in the analysis so as to capture all existing evidence on this question. When ≥2 randomized controlled trials (RCTs) were available, a planned subgroup analysis of only the RCTs was performed. We could then determine whether the outcome effect persisted when the lesser quality evidence was excluded from the analysis.
Data Extraction
Reviewers extracted data independently from the included studies in duplicates, using a standardized, piloted, Web-based form that was developed based on the protocol. Data extracted included: demographics of participants, patient inclusion criteria, study design, intervention details, and outcomes of interest. For all outcomes, we extracted dichotomous data whenever available including number of patients with any stage ROP, severe ROP, ROP requiring treatment, and in-hospital mortality, as well as total numbers in each arm. When this data were not available, we used the effect measures reported by the individual studies (relative risks, odds ratios) along with the corresponding 95% confidence intervals (CIs) for the meta-analysis. Outcome data were extracted at the last follow-up reported. All disagreements or differences in extracted data were resolved by consensus.
Methodological Quality and Risk of Bias Assessment
Randomized trials were evaluated using the Cochrane risk of bias assessment tool. 15 For every study, the following was determined: how the randomization sequence was generated, whether allocation was concealed, who was blinded, the degree of loss of follow-up, and the nature of funding sources. Observational studies were evaluated using the Newcastle-Ottawa tool. 16 This tool included the assessment of how the subjects represented the population of interest, how the comparative group was selected, how outcome was assessed, and the length and adequacy of follow-up when applicable. All discrepancies were resolved by a third reviewer with expertise in methodology.
Statistical Analysis
The reviewers extracted the contingency table data from the included studies to calculate the relative risks. We conducted a meta-analysis to pool relative risks using the random effect model to account for heterogeneity between studies as well as within-study variability. 17 We used the I 2 statistic to estimate the percentage of total between-study variation due to heterogeneity rather than chance (ranging from 0% to 100%). 18, 19 I 2 values of 25%, 50%, and 75% are thought to represent low, moderate, and high heterogeneity, respectively. Statistical analyses were conducted through OpenMeta. 20 All values are two-tailed and P < .05 was set as the threshold for statistical significance.
RESULTS
Study Selection
The flow diagram for study selection can be seen in Fig 1. From the database search and other sources, a total of 1479 records were identified for screening. Eighty-five studies were included in the qualitative analysis. We eventually identified 67 studies that provided quantitative data and they were included in the meta-analysis.
Study Characteristics
Twenty-seven studies on postnatal nutrition were included in the meta-analysis. These were further categorized into studies on the effect of human milk, 21 10, [65] [66] [67] [68] and the other 13 studied the effect of exogenous erythropoietin (EPO) on the risk of ROP. [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] All 5 studies of infection prevention pertained to the effect of fluconazole prophylaxis. [82] [83] [84] [85] [86] 
Risk of Bias Assessment
The risk of bias evaluation of the included studies is summarized in Figs 2 and 3. For the 85 studies included in qualitative analysis, 55 were RCTs and 30 were observational studies. The included RCTs showed an overall medium risk of bias. Almost half of them were unblinded. The risk of bias assessment of the included observational studies showed low to medium risk of bias. These studies exhibited risk of bias in areas such as outcome assessment, follow-up sufficiency, and length of follow-up. Table 1 ), but it had no effect on the incidence of severe ROP or mortality. Supplementation with vitamin E did not affect rates of any stage ROP. When analyzing both RCTs and observational studies, vitamin E supplementation was found to reduce the risk of developing severe ROP by 51% (RR 0.49, 95% CI, 0.24-0.98; Fig 4, Table 1 ). However, when the single observational study was removed and only the RCTs were analyzed, there was no longer a significant reduction in the risk of severe ROP (RR 0.52, 95% CI, 0.23-1.14). The 2 studies on lutein supplementation revealed no effect on the risk of any stage ROP, severe ROP, or death before discharge. The incidence of any stage ROP was not impacted by inositol supplementation. However, the 2 studies of inositol administration either as an intravenous medication or via formula feeds demonstrated a significantly reduced overall relative risk of severe ROP when compared with controls with no or minimal inositol exposure (RR 0.14, 95% CI, 0.03-0.69; Fig 4, Table 1 ).
Synthesis of Results
Postnatal Nutritional Interventions
Management of supplemental oxygen
Studies on the management of supplemental oxygen were primarily focused on oxygen saturation targeting ( Table 2) . Meta-analysis revealed that lower oxygen saturation targets, as defined by each study, resulted in a 14% reduction in the risk of developing any stage ROP (RR 0.86, 95% CI, 0.77-0.97; Fig 5, Table 2 ).
Fifteen studies of oxygen saturation targeting were analyzed for effect on severe ROP rates. When compared with higher oxygen saturation targets, lower oxygen saturation targets were associated with a 42% reduced risk of severe ROP or ROP requiring surgery (RR 0.58, 95% CI, 0.46-0.74; Fig 5, Table 2 ). When observational studies were excluded, analysis of the 4 RCTs demonstrated a nearly significant overall reduced risk of severe ROP for infants with oxygen saturation targets of 85% to 89% when compared with those with targets of 91% to 95% (RR of 0.72, 95% CI, 0.51-1.00; Fig 5, Table 2 ). Table  2 ). This finding remained significant when the 4 RCTs comparing oxygen saturation targets of 85% to 89% to targets of 91% to 95% were analyzed (RR 1.17, 95% CI, 1.03-1.32; Fig 5 , Table 2 ).
Management of Red Blood Cell Transfusions
Studies on the management of PRBC transfusions focused on 2 primary interventions: the use of hemoglobin transfusion guidelines and administration of EPO ( 
Interventions for Infection Reduction
There were 9 studies on the effect of infection reduction interventions on rates of ROP; however, only those on fluconazole prophylaxis for the prevention of fungal infection had a sufficient number of studies to allow for quantitative analysis (Table 4) . 
DISCUSSION
Summary of Evidence
Although there are few, focused systematic reviews on the prevention of ROP, [87] [88] [89] this is the first comprehensive meta-analysis of interventions aimed at multiple modifiable risk factors thought to be associated with an increased incidence of ROP. Our review revealed multiple subcategories of postnatal nutritional interventions. Meta-analysis of 2 cohort studies 22, 25 on the effect of breast milk versus formula feeds found a 60% reduction in the risk of severe ROP. This favorable finding was complicated by the need to categorize intervention and control groups as only or mainly breast milk fed compared with only or mainly infant formula fed, respectively. This classification was necessary because of the variability between studies in reporting enteral feed type, volume, exclusivity, duration, etc. The intervention group in the study by Hylander et al 22 received 20% to 100% human milk feeding whereas the control group was exclusively formula fed. Comparatively, the Maayan-Metzger et al 25 intervention group received at least 5 of 8 meals as human milk during the first month of life, whereas the control group received ≤3 human milk feeds. We also found that an exclusive human milk diet may have a favorable effect on the risk of mortality before discharge for preterm infants. The 2 RCTs of 7 by guest on November 15, 2017 http://pediatrics.aappublications.org/ Downloaded from was no longer significant when the single cohort study 40 was removed and only the RCTs were analyzed. In addition, 3 of the studies used intravenous vitamin E. Caution may be warranted when prescribing intravenous vitamin E to preterm infants because previous evidence has raised concern for an increased risk of sepsis with this route of administration. 93 Inositol is a nonglucose carbohydrate that may play an important role in early development and is involved in cell signaling, neuronal development, and pulmonary surfactant production. 94 For reference, the average concentration of inositol in preterm milk is ∼1350 μmol/L (or 240 mg/L). 95 The commonly prescribed preterm infant formulas currently in use contain 280 to 350 mg/L of inositol. [96] [97] [98] Analysis of the single cohort study 44 and 1 RCT 45 of inositol supplementation revealed a significantly reduced overall relative risk of severe ROP. In the first study, Friedman et al 44 studied the effect of a high inositol infant formula (2500 μmol/L or 450 mg/L) on rates of severe ROP. The second study by Hallman et al 45 supplemented neonates in the intervention group with intravenous inositol (80 mg/ kg per day for the first 5 days of life). Although this limited meta-analysis of 2 studies suggests that inositol could positively affect rates of severe ROP, additional data should be forthcoming in the next 2 to 5 years. The Eunice Kennedy Shriver National Institute of Child Health and Human Development is currently recruiting participants for a phase 3, randomized, placebocontrolled study to determine the effectiveness of myo-inositol injection on increasing the incidence of survival without severe ROP in preterm neonates <28 weeks gestation (www. clinicaltrials. gov, identifier NCT01954082). 99 Our quantitative meta-analysis of supplemental oxygen management focused on the effect of oxygen saturation targets on rates of ROP. Lower oxygen saturation targets, as defined by each study, reduced the rate of any stage ROP by nearly 15% when all study designs were analyzed. 48 The remaining 46% were part of a cohort study that frequently involved investigating ROP outcomes after a change in clinical management of supplemental oxygen. 49, 51, [54] [55] [56] [57] [58] [59] [60] [61] [62] In these studies, the definition of "lower oxygen saturation target" varied from a low of 70% to 90% 62 to a high of 90% to 96%. 58 The definition of "higher oxygen saturation target" ranged from a low of 88% to 96% 49 to a high of 95% to 100%. 56 Based on our meta-analysis, the risk of severe ROP or ROP requiring intervention was reduced by 40% using lower oxygen saturation targets as defined by each study.
However, this approach to oxygen management appears to be associated with undesirable effects on mortality before hospital discharge. When all study types were analyzed, we found an unacceptable 15% increased risk of mortality before discharge with lower oxygen saturation targets. Interestingly, 9 49-52, 54, 55, 58, 60, 62 of the 13 cohort studies did not report in-hospital mortality rates as an additional outcome.
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TABLE 4
Meta Analysis limited to the 4 RCTs 48, 53, 63, 64 again demonstrated a 17% increased risk of in-hospital mortality for those infants with a lower oxygen saturation target (85-90%) when compared with those with a higher oxygen saturation target (91-95%). Our overall relative risk of in-hospital mortality (RR 1.17) is lower than that reported in the NEOPROM collaborative study 8 (RR 1.41, 95% CI, 1.14-1.74). In the NEOPROM study, only the infants monitored with the revised oximeter calibration algorithm were included in their death at discharge analysis. These infants may have spent more time in the intended lower oxygen saturation range resulting in a greater increased risk of death.
We also evaluated ROP outcomes for interventions aimed at managing PRBC transfusions: primarily the use of hemoglobin transfusion guidelines and administration of EPO. However, we found no significant impact of either intervention on rates of any stage ROP, severe ROP, or ROP requiring intervention. Although our meta-analysis includes additional recently available studies, the findings are similar to previously published Cochrane reviews. [100] [101] [102] There is very little literature published on reducing the risk of infection in preterm neonates and its effect on the incidence of ROP. Although there are single studies of interventions to prevent infection that also report ROP outcomes, [103] [104] [105] only those studying fluconazole prophylaxis had sufficient numbers for quantitative analysis. Despite a reduced risk of invasive fungal infection, fluconazole prophylaxis has no significant effect on the risk of developing severe ROP.
Limitations
The greatest limitation of this metaanalysis is the overall absence of large, well-designed clinical studies in the literature. Approximately 75 000 neonates are born at <32 completed weeks of gestation each year in the United States, 106 and ROP is one of the key morbidities that can lead to long-term neurodevelopmental impairment in these infants. The results of this study suggest that there is a significant need for enhanced translational and clinical research to better understand how ROP can safely be prevented in very preterm neonates.
Among the studies included in this meta-analysis, the format for reporting ROP outcomes was highly variable (eg, by stage, type, prethreshold/threshold, need for surgery, etc). To address this issue, we analyzed ROP outcomes using 2 categories: (1) presence of any stage ROP, and (2) ROP that was likely to result in an unfavorable visual outcome. An undesirable retinal outcome included patients with severe ROP (stage ≥3), type 1 threshold ROP, or ROP requiring medical or surgical intervention. If a single study reported undesirable retinal outcomes in multiple formats, the rate of severe ROP was used to provide increased sensitivity and similarity between articles. The use of common standards for ROP outcomes research is needed.
This meta-analysis was also limited by the heterogeneity of interventions even within categories as previously described (eg, variation in vitamin and medication dosages/regimens, parenteral and enteral feeding strategies, definition of oxygen saturation targets, hemoglobin transfusion guidelines, etc). However, study characteristics were thoughtfully reviewed before the meta-analyses in an effort to provide a meaningful synthesis of the current evidence on the prevention of ROP to guide care of the preterm infant. 
CONCLUSIONS
